Alprenolol is a non-selective beta-adrenergic receptor antagonist primarily indicated for the management of hypertension, edema, and cardiac arrhythmias, including ventricular tachycardia and atrial fibrillation.… Read more
Alprenolol is a non-selective beta-adrenergic receptor antagonist primarily indicated for the management of hypertension, edema, and cardiac arrhythmias, including ventricular tachycardia and atrial fibrillation. As a critical pharmaceutical agent, ensuring its efficacy and safety profile requires rigorous analytical monitoring. This category features high-quality reference standards of Alprenolol, its hydrochloride salt, and a range of associated chemical impurities. Pharmaceutical laboratories utilize these materials for comprehensive impurity profiling, ensuring compliance with established pharmacopeial monographs. Furthermore, the inclusion of stable isotope labelled compounds provides essential internal standards for quantitative analysis in complex matrices, enabling precise method validation and quality control throughout the drug manufacturing and development lifecycle. By accurately identifying and quantifying degradation products and synthesis byproducts, these reference materials support the regulatory and safety standards mandated for active pharmaceutical ingredients.